Lilly Receives Complete Response Letter From FDA for Liprotamase for the Treatment of Exocrine Pancreatic Insufficiency
Links shared publicly online about this topic.
- 317total visits
Lilly Receives Complete Response Letter From FDA for Liprotamase for the Treatment of Exocrine Pancreatic Insufficiency
View full resource at drugs.com
Tags: Pancreatic Disease, Drug, Clinical Trial, FDA, News
Most Recently Shared on May 5, 2011 at 12:15 am By:
Lilly Receives Complete Response Letter From FDA for Liprotamase for the Treatment of Exocrine Pancreatic ... http://bit.ly/jOU4X2 #drug
Lilly Receives Complete Response Letter From FDA For Liprotamase For The Treatment Of Exocrine Pancreatic Insufficiency
medicalnewstoday.com — “Eli Lilly and Company (NYSE: LLY) has received a complete response letter from the U.S. Food and Drug Administration (FDA) for its New Drug Application (NDA) for liprotamase, a non-porcine pancrea” View full resource at medicalnewstoday.com
Most Recently Shared on April 20, 2011 at 7:05 am By:
MNT Drug Approvals Health News
Lilly Receives Complete Response Letter From FDA For Liprotamase For The Treatment Of Exocrine Pancreatic Insufficiency http://mnt.to/3TR6
Eli Lilly receives FDA complete response letter for liprotamase NDA
news-medical.net — “Eli Lilly and Company has received a complete response letter from the U.S. Food and Drug Administration for its New Drug Application for liprotamase, a non-porcine pancreatic enzyme replacement therapy, under investigation for the treatment of exocrine pancreatic insufficiency.” View full resource at news-medical.net
Most Recently Shared on April 16, 2011 at 5:51 am By:
Eli Lilly receives FDA complete response letter for liprotamase NDA: Eli Lilly and Company has received a comple... http://bit.ly/fsQvtO
Advertisement
